Dronemaker Destinus to Buy AI Aviation Firm for $223 Million
The deal for Zurich-based Daedalean will boost Destinus's artificial intelligence capabilities as it develops strike drones and hypersonic aircraft, the companies said in a statement on Tuesday. They expect the transaction to close by the end of year.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Wall Street stocks end lower as rally peters out
Wall Street stocks fell Tuesday as a rally ran out of steam following lackluster economic data, while investors monitor ongoing trade talks ahead of new tariff hikes set to take effect later this week. US President Donald Trump told CNBC he plans fresh tariffs on imported pharmaceuticals and semiconductors. Trump also said he expects to raise the US tariff on Indian imports due to the country's purchases of Russian oil. The statements come before a separate set of tariff hikes goes into force on dozens of economies later this week. Swiss officials traveled to Washington Tuesday to try to strike a last-minute deal. Investors also digested an index of US services activity that came in at 50.1 percent, just barely in growth mode as companies contend with weaker hiring conditions and increased pricing pressure. The report comes on the heels of jobs data last Friday that pointed to slowing in the labor market. On the positive side, "a weaker economy could mean more rate cuts from the Fed," said Adam Sarhan of 50 Park Investments. After opening higher, US indices fell into negative territory, with the S&P 500 ending down 0.5 percent. European markets ended mixed, with Paris dipping into the red, while oil prices retreated further on worries about the demand outlook. Swiss leaders flew to Washington on Tuesday in a last-ditch effort to avoid a hefty 39-percent tariff. Meanwhile, the European Union on Tuesday announced the suspension of its retaliatory tariffs on US goods worth 93 billion euros ($107 billion) after Brussels struck a deal with Washington last month. Among individual companies, Palantir Technologies jumped 7.9 percent after reporting its first quarter with more than $1 billion in revenues. The data analysis and artificial intelligence company also raised its full-year revenues forecast. Pfizer was another big winner after earnings as the drugmaker reported a big increase in profits to $2.9 billion behind higher sales of Covid-19 products and lower expenses. Shares jumped 5.2 percent. Diageo, the maker of Guinness stout and Smirnoff Vodka, rose 4.9 percent after raising its cost-savings targets following a sharp drop profits to the hit from US tariffs. - Key figures at around 2100 GMT - New York - Dow: DOWN 0.1 percent at 44,111.74 (close) New York - S&P 500: DOWN 0.5 percent at 6,299.19 (close) New York - Nasdaq Composite: DOWN 0.7 percent at 20,916.55 (close) London - FTSE 100: UP 0.2 percent at 9,142.73 (close) Paris - CAC 40: DOWN 0.1 percent at 7,621.04 (close) Frankfurt - DAX: UP 0.4 percent at 23,846.07 (close) Tokyo - Nikkei 225: UP 0.6 percent at 40,549.54 (close) Hong Kong - Hang Seng Index: UP 0.7 percent at 24,902.53 (close) Shanghai - Composite: UP 1.0 percent at 3,617.60 (close) Euro/dollar: UP at $1.1582 from $1.1571 on Monday Pound/dollar: UP at $1.3294 from $1.3285 Dollar/yen: UP at 147.55 yen from 147.09 yen Euro/pound: DOWN at 87.01 pence from 87.10 pence West Texas Intermediate: DOWN 1.7 percent at $65.16 per barrel Brent North Sea Crude: DOWN 1.7 percent at $67.64 per barrel burs-jmb/st Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Ottawa signs contract with Canadian firm to make drones for Halifax-class ships
OTTAWA — The federal government has contracted a Canadian firm to outfit the Royal Canadian Navy's Halifax-class ships with a small fleet of aerial drones. Ottawa announced it has awarded two contracts to MDA Space for up to six advanced 'uncrewed aircraft systems' for the Navy's patrol frigates. The Department of National Defence says in a news release that this will boost the navy's long-range maritime surveillance abilities. The department has earmarked $39 million to acquire the first two drones, with an option of ordering another four. The initial five-year service contract is estimated to be worth $27 million and its time frame could be extended by the department to 20 years. The new drone capability is expected to start coming online in 2028 and to be working at full capacity by 2032. This report by The Canadian Press was first published Aug. 5, 2025. The Canadian Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Medtronic to announce financial results for its first quarter of fiscal year 2026
GALWAY, Ireland, Aug. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, for its first quarter of fiscal year 2026, which ended on Friday, July 25, 2025, A news release containing summary financial information will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at A video webcast to discuss results will begin at 7:00 a.m. CDT and can be accessed at Within 24 hours of the video webcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at Looking ahead, Medtronic plans to report its fiscal year 2026 second, third, and fourth quarter results on Tuesday, November 18, 2025, February 17, 2026, and Wednesday, May 20, 2026, respectively. Confirmation and additional details will be provided closer to the specific event. About MedtronicBold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit and follow Medtronic on LinkedIn. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. Contacts:Erika WinkelsPublic Relations+1-763-526-8478 Ryan WeispfenningInvestor Relations+1-763-505-4626 View original content to download multimedia: SOURCE Medtronic plc Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
